Complications and Risk Factors Related With Central Venous Catheters in Cancer Patients
CVCCP
2 other identifiers
observational
3,500
1 country
1
Brief Summary
The investigators aim to determine the complications and risk factors related with peripherally inserted central catheters (PICCs) and central venous catheters (CVCs) in cancer patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 2, 2012
CompletedFirst Posted
Study publicly available on registry
August 9, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2019
CompletedSeptember 3, 2020
August 1, 2012
7 years
August 2, 2012
September 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Catheter-related venous thrombosis and catheter-related infections
Catheter-related venous thrombosis and catheter-related infections
30 days after PICC and CVC line withdrawn
Secondary Outcomes (1)
Catheter tip position
participants will be followed before PICC and CVC line withdrawn
Study Arms (1)
complications
catheter-related venous thrombosis catheter-related infections
Eligibility Criteria
All adult cancer patients with CVC and PICC placed at BeijingHCH and with written consent for this study
You may qualify if:
- all adult cancer patients with central venous catheters (CVCs) or peripherally inserted central catheters (PICCs) placed at BeijingHCH.
You may not qualify if:
- without written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Huanxing Cancer Hospital
Beijing, Beijing Municipality, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jian DING, MD
Beijing Huanxing Cancer Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2012
First Posted
August 9, 2012
Study Start
August 1, 2012
Primary Completion
August 1, 2019
Study Completion
August 1, 2019
Last Updated
September 3, 2020
Record last verified: 2012-08